Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 05, 2019

SELL
$144.16 - $172.9 $586,298 - $703,184
-4,067 Closed
0 $0
Q1 2019

Apr 30, 2019

SELL
$123.7 - $156.3 $1.04 Million - $1.31 Million
-8,393 Reduced 67.36%
4,067 $622,000
Q4 2018

Jan 11, 2019

SELL
$120.82 - $174.09 $228,953 - $329,900
-1,895 Reduced 13.2%
12,460 $1.57 Million
Q3 2018

Oct 10, 2018

SELL
$167.67 - $188.27 $713,771 - $801,465
-4,257 Reduced 22.87%
14,355 $2.49 Million
Q2 2018

Jul 09, 2018

SELL
$160.33 - $189.41 $140,288 - $165,733
-875 Reduced 4.49%
18,612 $3.34 Million
Q1 2018

Apr 23, 2018

SELL
$161.53 - $178.11 $90,941 - $100,275
-563 Reduced 2.81%
19,487 $3.15 Million
Q4 2017

Jan 24, 2018

BUY
$147.99 - $163.95 $522,108 - $578,415
3,528 Added 21.35%
20,050 $3.2 Million
Q3 2017

Oct 12, 2017

BUY
$149.47 - $160.56 $2.47 Million - $2.65 Million
16,522
16,522 $2.49 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.3B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Jlb & Associates Inc Portfolio

Follow Jlb & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jlb & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jlb & Associates Inc with notifications on news.